Tips from Other Journals

Risk Classification for Stroke, Death, and Atrial Fibrillation



FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.


FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2004 Apr 1;69(7):1753-1756.

As the U.S. population ages and the prevalence of cardiovascular disease increases, the prevalence of atrial fibrillation (AF) is expected to increase from its current level of 2 million persons. Given the risk of stroke in patients with AF, a reliable risk stratification scheme would help identify patients at high risk, especially those who would benefit from therapies such as warfarin. Current stratification schemes may be based on biased studies. Wang and colleagues tested a classification scheme for patients with AF that focused on stroke risk alone and stroke risk or death as outcomes.

Using data from the Framingham Heart Study, the authors identified 705 eligible persons with new-onset AF who were not treated with warfarin at baseline and were used in the creation of the risk scores. Baseline risk factor data included blood pressure measurements, presence or absence of diabetes, current cigarette smoking, valvular heart disease, and left ventricular hypertrophy. Previous myocardial infarction, congestive heart failure, transient ischemic attack, or stroke also were evaluated in the analysis. Warfarin or aspirin use was determined by self-report. Primary outcomes were stroke alone and stroke or death. Analyses were conducted before and after excluding subjects who had received warfarin.

Predicted Five-Year Risk of Stroke

The rightsholder did not grant rights to reproduce this item in electronic media. For the missing item, see the original print version of this publication.

FIGURE 1.

During a mean follow-up of 4.3 years, stroke occurred in 111 persons (13 percent) and stroke or death occurred in 485 persons (56 percent). After excluding those who received warfarin, the analysis yielded 83 strokes and 382 strokes or deaths after 4.0 years. Results of the Cox proportional hazards analyses yielded the following predictors for stroke: female sex, diabetes, and previous stroke or transient ischemic attack. For stroke or death, the following predictors entered the model: smoking, diabetes, previous myocardial infarction or congestive heart failure, heart murmur, and left ventricular hypertrophy. Figures 1 and2 present a scoring system to predict five-year risk of stroke and combined stroke or death.

The results of this study are similar to results of previous studies with regard to risk factors such as diabetes, advancing age, and elevated blood pressure. By deriving clinical risk scores, the current classification scheme can be used to estimate the absolute risk of an adverse event in patients with AF. These results may influence clinical decision-making, particularly in patients who are at especially low or high risk.

Predicted Five-Year Risk of Stroke or Death

The rightsholder did not grant rights to reproduce this item in electronic media. For the missing item, see the original print version of this publication.

FIGURE 2.

Wang TJ, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study. JAMA. August 27, 2003;290:1049–56.


Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Article Tools

  • Print page
  • Share this page
  • AFP CME Quiz

Information From Industry

Navigate this Article